- Home
- GNTA vs BAFN Comparison
GNTA vs BAFN Comparison
Compare GNTA & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GNTA | BAFN |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.0M | 40.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GNTA | BAFN |
|---|---|---|
| Price | $1.40 | $7.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 100.3K | 7.3K |
| Earning Date | 03-30-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $58,931,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.28 | $6.40 |
| 52 Week High | $10.00 | $19.75 |
Technical Indicators
Market Signals| Indicator | GNTA | BAFN |
|---|---|---|
| Relative Strength Index (RSI) | 38.16 | 33.99 |
| Support Level | $1.35 | $7.57 |
| Resistance Level | $1.50 | $8.06 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 23.53 | 0.00 |
Price Performance
Historical ComparisonAbout GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios. The company has various segment such as Real Estate(Residential, Commercial, and Construction & Land), Commercial and Industrial, Consumer.